These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12164720)

  • 1. Progressive worsening of spatial and chromatic processing deficits in Parkinson disease.
    Diederich NJ; Raman R; Leurgans S; Goetz CG
    Arch Neurol; 2002 Aug; 59(8):1249-52. PubMed ID: 12164720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased color discrimination and contrast sensitivity in Parkinson's disease.
    Pieri V; Diederich NJ; Raman R; Goetz CG
    J Neurol Sci; 2000 Jan; 172(1):7-11. PubMed ID: 10620653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
    Bertrand JA; Bedetti C; Postuma RB; Monchi O; Génier Marchand D; Jubault T; Gagnon JF
    Mov Disord; 2012 Dec; 27(14):1781-8. PubMed ID: 23147270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor visual discrimination and visual hallucinations in Parkinson's disease.
    Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
    Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress of visual dysfunction in Parkinson's disease.
    Müller T; Woitalla D; Peters S; Kohla K; Przuntek H
    Acta Neurol Scand; 2002 Apr; 105(4):256-60. PubMed ID: 11939937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-perception and determinants of color vision in Parkinson's disease.
    Brandt AU; Zimmermann HG; Oberwahrenbrock T; Isensee J; Müller T; Paul F
    J Neural Transm (Vienna); 2018 Feb; 125(2):145-152. PubMed ID: 29143216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities in color vision and contrast sensitivity in Parkinson's disease.
    Price MJ; Feldman RG; Adelberg D; Kayne H
    Neurology; 1992 Apr; 42(4):887-90. PubMed ID: 1565248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary vision and facial emotion recognition in early Parkinson's disease.
    Hipp G; Diederich NJ; Pieria V; Vaillant M
    J Neurol Sci; 2014 Mar; 338(1-2):178-82. PubMed ID: 24484973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Color vision in Parkinson's disease and essential tremor.
    Oh YS; Kim JS; Chung SW; Song IU; Kim YD; Kim YI; Lee KS
    Eur J Neurol; 2011 Apr; 18(4):577-83. PubMed ID: 21435106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast sensitivity and other vision tests in the optic neuritis treatment trial.
    Trobe JD; Beck RW; Moke PS; Cleary PA
    Am J Ophthalmol; 1996 May; 121(5):547-53. PubMed ID: 8610798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Color vision in Parkinson's disease: missing influence of amantadine sulphate.
    Büttner T; Kuhn W; Müller T; Patzold T; Przuntek H
    Clin Neuropharmacol; 1995 Oct; 18(5):458-63. PubMed ID: 8665560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of IOL implantation on visual acuity, contrast sensitivity and colour vision 2 and 4 months after cataract surgery].
    Ventruba J
    Cesk Slov Oftalmol; 2006 Apr; 62(2):133-43. PubMed ID: 16640052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.
    Polo V; Satue M; Rodrigo MJ; Otin S; Alarcia R; Bambo MP; Fuertes MI; Larrosa JM; Pablo LE; Garcia-Martin E
    BMJ Open; 2016 May; 6(5):e009658. PubMed ID: 27154474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships Between Measures of the Ability to Perform Vision-Related Activities, Vision-Related Quality of Life, and Clinical Findings in Patients With Glaucoma.
    Ekici F; Loh R; Waisbourd M; Sun Y; Martinez P; Nayak N; Wizov SS; Hegarty S; Hark LA; Spaeth GL
    JAMA Ophthalmol; 2015 Dec; 133(12):1377-85. PubMed ID: 26425961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of apomorphine on visual functions in Parkinson's disease.
    Büttner T; Müller T; Kuhn W
    J Neural Transm (Vienna); 2000; 107(1):87-94. PubMed ID: 10809406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of reduced contrast sensitivity on colour vision testing.
    Lipsky L; Qureshi HM; Friling R; Gaton DD; Rabina G; Dotan G
    Eye (Lond); 2019 Jul; 33(7):1068-1072. PubMed ID: 30783257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of color perception in individuals addicted to narcotic substances in the Farnsworth-Munsell 100-Hue test].
    Nadolska K; Goś R
    Med Pr; 2016 Dec; 67(6):777-785. PubMed ID: 28005086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of retinopathy on the achromatic and chromatic vision of patients with type 2 diabetes.
    Andrade LC; Souza GS; Lacerda EM; Nazima MT; Rodrigues AR; Otero LM; Pena FP; Silveira LC; Côrtes MI
    BMC Ophthalmol; 2014 Aug; 14():104. PubMed ID: 25174264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical color vision testing and correlation with visual function.
    Zhao J; Davé SB; Wang J; Subramanian PS
    Am J Ophthalmol; 2015 Sep; 160(3):547-552.e1. PubMed ID: 26116263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.